Kreuter, A., Licciardi‐Fernandez, M. J., Burmann, S., Burkert, B., Oellig, F., & Michalowitz, A. (2022). Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA‐based or adenoviral vector‐based SARS‐CoV‐2 vaccination. Clinical & Experimental Dermatology, 47(1), 161. https://doi.org/10.1111/ced.14858
Chicago Style (17th ed.) CitationKreuter, A., M. J. Licciardi‐Fernandez, S.‐N Burmann, B. Burkert, F. Oellig, and A.‐L Michalowitz. "Induction and Exacerbation of Subacute Cutaneous Lupus Erythematosus Following MRNA‐based or Adenoviral Vector‐based SARS‐CoV‐2 Vaccination." Clinical & Experimental Dermatology 47, no. 1 (2022): 161. https://doi.org/10.1111/ced.14858.
MLA (9th ed.) CitationKreuter, A., et al. "Induction and Exacerbation of Subacute Cutaneous Lupus Erythematosus Following MRNA‐based or Adenoviral Vector‐based SARS‐CoV‐2 Vaccination." Clinical & Experimental Dermatology, vol. 47, no. 1, 2022, p. 161, https://doi.org/10.1111/ced.14858.